| carbidopa | <chemical> A peripheral inhibitor of dopa decarboxylase. It is given in parkinsonism along with levodopa to inhibit the conversion of levodopa to dopamine in the periphery, thereby reducing the peripheral adverse effects, increasing the amount of levodopa that reaches the central nervous system, and reducing the dose needed. It has no antiparkinson actions when given alone. Pharmacological action: antiparkinson agents, dopamine agents, enzyme inhibitors. Chemical name: Benzenepropanoic acid, alpha-hydrazino-3,4-dihydroxy-alpha-methyl-, monohydrate, (S)- (12 Dec 1998) |
|---|
Synonyms : Carbidopa, (R)-Isomer, Carbidopa, (S)-Isomer, Lodosin, Lodosyn, MK-485, MK-486, MK 485, MK 486, MK485, MK486
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|---|---|---|---|
|
시네메트씨알정 - 새창
|
Merck |
E09060041 | Carbidopa, Levodopa | 전문의약품 | 급여 |
|
시네메트정25/100 - 새창
|
한국엠에스디 |
W09060041 | Carbidopa, Levodopa | 전문의약품 | 급여 |
|
이시콤정 - 새창
|
한국유나이티드제약 |
A12903001 | Carbidopa, Levodopa | 전문의약품 | 급여 |
|
퍼킨정25/250mg - 새창
|
명인제약 |
A09202171 | Carbidopa, Levodopa | 전문의약품 | 급여 |
|
프로매트정 - 새창
|
초당약품 |
A33050111 | Carbidopa, Levodopa | 전문의약품 | 급여 |
|
시네메트정 - 새창
|
한국엠에스디 |
W09060011 | Carbidopa, Levodopa | 전문의약품 | 급여 |
|
레돕산정25/100 - 새창
|
사노피-아벤티스코리아 |
W03000031 | Carbidopa, Levodopa | 전문의약품 | 삭제 |
|
레돕산정25/250 - 새창
|
사노피-아벤티스코리아 |
W03000021 | Carbidopa, Levodopa | 전문의약품 | 삭제 |
|
이시콤정125mg - 새창
|
한국유나이티드제약 |
A12942451 | Carbidopa, Levodopa | 전문의약품 | 삭제 |
|
도파큐정 - 새창
|
씨트리 |
A13851331 | Carbidopa, Levodopa | 전문의약품 | 삭제 |
| carbidopa |
The decarboxylase inhibitor that is co-administered with levodopa in Sinemet ?br>
출처: www.parkinsonsdisease.com/lwp/glossary.htm
|
|---|---|
| carbidopa |
administered with L-dopa in the treatment of Parkinson's disease to increase the amount of L-dopa available for transport to the brain.
출처: www.diatxzn.com/Terminology/
|
| carbidopa |
a drug given in combination with levodopa in order to treat Parkinson
출처: www.levodopaandsinemet.com/levodopa_glossary.php
|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|